Antibodies against polysaccharide type 3 and pneumococcal proteins demonstrate synergistic protective effect in a highly virulent type 3 invasive disease model in mice

Streptococcus pneumoniae serotype-3 (ST-3) continues to be a major contributor to pneumococcal disease burden despite its inclusion in multivalent pneumococcal conjugate vaccines (PCV). Therefore, there is a pressing need to develop vaccines that can elicit more versatile immune responses against ST...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Taylor C. Stevenson, Heidi Burke, Sara E. Roggensack, Anthony Pratt, Aquib Hossain, Pallab Ghosh, Gilles Besin, Yingjie Lu, Fan Zhang, Richard Malley, Shite Sebastian
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-12-01
Edice:	Frontiers in Immunology
Témata:	Streptococcus pneumoniae (pneumococcus) serotype 3 vaccine MAPS pneumolysin
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1707686/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!